secwatch / observer
8-K filed November 26, 2025, 6:59 PM ET ticker VSEE CIK 0001864531
other material confidence high sentiment neutral materiality 0.60

VSee Health raises ~$6M in private placement of common shares and warrants

VSEE HEALTH, INC.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

VSEE HEALTH, INC. issued up to 19,672,130 shares of Common Stock of warrant to a single institutional and accredited investor for exercise price of $0.61 per share.

Security
warrant
Shares
up to 19,672,130 shares of Common Stock
Purchaser
a single institutional and accredited investor
Consideration
exercise price of $0.61 per share
Exact text from the filing
million, before deducting the placement agent’s fees and other estimated offering expenses. The purchase price per Share (or Pre-Funded Warrant) and the accompanying Warrants is $0.61. The Warrants will be exercisable immediately following receipt of stockholder approval for the issuance of the Warrants and the shares of Common Stock underlying the Warrants
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

VSEE HEALTH, INC. issued warrant to a single institutional and accredited investor for $0.0001 per share.

Security
warrant
Purchaser
a single institutional and accredited investor
Consideration
$0.0001 per share
Exact text from the filing
pre-funded warrants exercisable for $0.0001 per share in lieu thereof (“Pre-Funded Warrants”)
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

VSEE HEALTH, INC. issued 9,836,065 shares of common stock to a single institutional and accredited investor for purchase price per Share ... is $0.61.

Security
common stock
Shares
9,836,065 shares
Purchaser
a single institutional and accredited investor
Consideration
purchase price per Share ... is $0.61
Exact text from the filing
million, before deducting the placement agent’s fees and other estimated offering expenses. The purchase price per Share (or Pre-Funded Warrant) and the accompanying Warrants is $0.61. The Warrants will be exercisable immediately following receipt of stockholder approval for the issuance of the Warrants and the shares of Common Stock underlying the Warrants
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VSEE HEALTH, INC. entered into Purchase Agreement with a single institutional and accredited investor (the “Purchaser”) valued at approximately $6 million (effective 2025-11-25).

Action
entry
Agreement
equity purchase
Counterparty
a single institutional and accredited investor (the “Purchaser”)
Value
approximately $6 million
Effective
2025-11-25
Exact text from the filing
On November 25, 2025, VSee Health, Inc. (the “Company”) and a single institutional and accredited investor (the “Purchaser”) entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell to the Purchaser an aggregate of 9,836,065 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), or pre-funded warrants exercisable for $0.0001 per share in lieu thereof (“Pre-Funded Warrants”), and accompanying common warrants to purchase up to 19,672,130 shares of Common Stock (the “Warrants”) in a private placement (the “Offering”), for gross proceeds of approximately $6 million, before deducting the placement agent’s fees and other estimated offering expenses.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VSEE HEALTH, INC. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2025-11-25).

Action
entry
Agreement
underwriting
Counterparty
A.G.P./Alliance Global Partners (the “Placement Agent”)
Effective
2025-11-25
Exact text from the filing
Pursuant to a placement agent agreement (the “Placement Agent Agreement”) between the Placement Agent and the Company, dated November 25, 2025, the Company agreed to pay the Placement Agent a cash fee equal to 7% of the aggregate gross proceeds raised in the Offering, and to reimburse the Placement Agent for certain reasonable, documented, and accountable expenses, including legal fees, of $50,000 in the aggregate, and non-accountable expenses of $10,000.
View on SEC.gov

Browse all equity issuances →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR
accession 0001185185-25-001870
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.